Surface oncology, inc. (SURF)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows from operating activities:
Net income (loss)

22,570

-15,954

-16,878

-17,758

-4,199

-4,735

-17,222

-15,852

31,212

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-8,626

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense

457

461

453

441

430

365

334

327

321

307

262

237

158

Stock-based compensation expense

1,850

1,545

1,566

1,485

1,395

1,222

1,214

1,490

1,291

673

2,804

729

503

Non-cash interest expense related to note payable

176

-

-

-

-

-

-

-

-

-

-

-

-

Net amortization of premiums and discounts on marketable securities

42

98

202

276

188

170

185

92

-70

-109

-112

-131

-164

Realized losses on marketable securities

-

-

-

-

-

-

-

-

-

0

0

0

-2

Loss on disposal of property and equipment

-1

-

-

-

-

-1

0

0

-13

0

0

0

-35

Non-cash operating lease cost

587

949

287

287

291

-

-

-

-

-

-

-

-

Deferred income tax benefit

-

-

-

-

-

-

-

-

-

-

-1,491

-719

-946

Changes in operating assets and liabilities:
Amounts due from related party

-

-

-

-

-

-

-

-

-

0

0

0

-5,000

Prepaid expenses and other current assets

444

261

-736

-1,449

-1,077

1,228

-3,896

1,111

-613

68

-1,657

-515

1,016

Other assets

138

-7

24

-38

9

-28

53

6

-5

-

-

-

-

Accounts payable

-2,651

1,737

-257

-1,799

902

-1,121

1,156

-3,705

3,693

-777

1,729

-3,711

3,044

Accrued expenses and other current liabilities

-467

-409

546

2,452

-3,299

1,440

395

3,294

-5,653

428

2,415

551

-449

Deferred rent

-

-

-

-

-

-21

-50

64

59

48

47

-29

-315

Operating lease liability

17

-950

-277

-277

-274

-

-

-

-

-

-

-

-

Other liabilities

1,100

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - related party

-38,592

-439

-344

-143

-14,434

-9,765

-1,731

-2,426

-495

-

-

-

-

Deferred revenue - related party

-

-

-

-

-

-

-

-

-

-

-2,479

23,805

-1,672

Net cash used in operating activities

-15,576

-13,338

-14,393

-14,101

-18,308

-13,942

-12,146

-18,145

31,011

-

-

-

-

Cash flows from investing activities:
Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-3,488

Purchases of property and equipment

23

131

270

261

876

1,123

285

131

480

578

57

243

1,095

Purchases of marketable investments

650

10,563

14,325

23,158

70,301

-

-

-

-

-

-

-

-

Proceeds from sales or maturities of marketable securities

25,500

25,501

29,749

33,925

47,675

56,100

3,234

7,158

6,200

7,001

2,299

4,000

14,591

Net cash provided by (used in) investing activities

24,827

14,807

15,154

10,506

-23,502

54,978

2,949

-100,231

5,720

-

-

-

-

Cash flows from financing activities:
Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

13,496

Payments of initial public offering costs

-

-

-

-

-

0

0

1,976

55

-

-

-

-

Proceeds from issuance of common stock upon public offering, net

320

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from employee stock purchases

83

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

10

0

11

33

211

284

24

2

157

-

-

-

-

Net cash provided by financing activities

413

7,160

11

33

211

284

24

109,966

102

-

-

-

-

Net increase (decrease) in cash and cash equivalents and restricted cash

9,664

8,629

772

-3,562

-41,599

41,320

-9,173

-8,410

36,833

-

-

-

-

Net increase in cash and cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-7,437

18,754

10,008

Supplemental disclosure of cash flow information:
Cash paid for interest

180

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-13

0

27

14

-

-

32

61

Supplemental disclosure of non-cash investing and financing activities:
Additional right-of-use asset and related lease liability

15,003

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

0

0

0

11

10

10

10

10

Deferred Offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

1,450

-

-

-

-

Purchases of property and equipment included in accounts payable and accrued expenses

-

-

-203

78

137

370

216

56

50

204

238

-159

167

Reclassification of deposit liability for restricted stock upon vesting of shares

-

-

-

-

-

-

-

-

-

-1

29

3

4

Landlord incentives for construction of leasehold improvements recorded as deferred rent

-

-

-

-

-

-

-

-

-

0

186

934

1,257